Year: 2026

RenX Enterprises Corp. Beats Revenue Guidance, Delivering $8.2 Million in Post-Acquisition Revenue While Completing Full Platform Buildout and Retiring $11.9 Million in Legacy Debt

Written by Customer Service on April 1, 2026. Posted in Earnings Releases And Operating Results.

MIAMI, April 01, 2026 (GLOBE NEWSWIRE) — RenX Enterprises Corp. (NASDAQ: RENX) today announced financial results for the fiscal year ended December 31, 2025. The growing media and substrate industry runs on imported raw materials. Peat is harvested in Canada and Eastern Europe. Coconut coir is processed in Southeast Asia. Both travel thousands of miles before they reach a North American greenhouse or a bag on a retail shelf. Producers who depend on this supply chain are facing a structural problem: input costs are rising, import dependencies are deepening, and sourcing alternatives quickly is not straightforward. The industry has been waiting for a domestic solution that can produce at scale, at the right quality, and at a cost that makes the import dependency look like what it increasingly is: a disadvantage. RenX was built to...

Watsco Declares $3.30 Quarterly Dividend

Written by Customer Service on April 1, 2026. Posted in Dividend Reports And Estimates.

Reflects 10% Increase to Annual Rate of $13.20 Per Share MIAMI, April 01, 2026 (GLOBE NEWSWIRE) — Watsco, Inc.’s (NYSE: WSO) Board of Directors has declared a regular quarterly cash dividend of $3.30 on each outstanding share of its Common and Class B common stock payable on April 30, 2026 to shareholders of record at the close of business on April 16, 2026. This marks a 10% increase to an annual rate of $13.20 per share. Albert H. Nahmad, Watsco’s Chairman & CEO stated: “We are pleased to increase dividends to shareholders, reflecting our continued confidence in our business, which is fundamentally supported by our strong balance sheet.” Watsco has paid dividends to shareholders for 52 consecutive years. The Company’s philosophy is to share cash flow through dividends while maintaining a conservative balance sheet with continued...

Brookfield Infrastructure to Host First Quarter 2026 Results Conference Call

Written by Customer Service on April 1, 2026. Posted in Public Companies.

BROOKFIELD, NEWS, April 01, 2026 (GLOBE NEWSWIRE) — Brookfield Infrastructure Partners will hold its first quarter 2026 conference call and webcast on Wednesday, April 29, 2026, at 9:00 a.m. (ET). Results will be released that morning before 7:00 a.m. (ET) and will be available on our website at https://bip.brookfield.com. Participants can join by conference call or webcast. Conference CallPlease pre-register at: BIP2026Q1ConferenceCall Upon registering, you will be emailed a dial-in number and unique PIN. This process will bypass the operator and avoid the queue.WebcastPlease join and register at: BIP2026Q1WebcastAbout Brookfield Infrastructure Brookfield Infrastructure is a leading global infrastructure company that owns and operates high-quality, long-life assets in the utilities, transport, midstream and data sectors...

Rapport Therapeutics to Present New Phase 2 Treatment Follow-Up Data for RAP-219 in Focal Onset Seizures at the 2026 American Academy of Neurology Annual Meeting

Written by Customer Service on April 1, 2026. Posted in Public Companies.

BOSTON and SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced that it will present results from its Phase 2a trial of RAP-219 in patients with focal onset seizures (FOS), including new data from the 8-week follow-up period, in a podium presentation at the upcoming 2026 American Academy of Neurology (AAN) Annual Meeting, taking place April 18-22 in Chicago. Presentation DetailsTitle: Efficacy and Tolerability of RAP-219, a Potential First-in-Class Negative Allosteric Modulator of γ8 Transmembrane AMPA Receptor Regulatory Protein: Impact on RNS Long Episodes and Clinical Seizures Presenter: William...

CLEAN Announces Premier American Uranium as a Silver Sponsor of the 1st Annual Nuclear in New Mexico Conference

Written by Customer Service on April 1, 2026. Posted in Public Companies.

SANTA FE, N.M. and TORONTO, April 01, 2026 (GLOBE NEWSWIRE) — The Clean Energy Association of New Mexico (“CLEAN”) and Premier American Uranium (“PUR”, the “Company” or “Premier American Uranium”) (TSXV: PUR) (OTCQB: PAUIF) are pleased to announce that PUR will serve as a Silver Sponsor of the inaugural Nuclear in New Mexico: Fueling the U.S. Nuclear Renaissance conference. The conference is taking place April 20th to 22nd, 2026, at the Hyatt Regency Tamaya Resort & Spa, located on the Santa Ana Pueblo just north of Albuquerque, New Mexico. Colin Healey, CEO of Premier American Uranium Inc., commented, “We are proud to support the inaugural Nuclear in New Mexico Conference, particularly as we continue to advance our Cebolleta Project. Following the completion of our robust PEA last year, our 2026 programs are focused on further...

Green Thumb Industries Announces Amendment to Brand Transactions with RYTHM, Inc.

Written by Customer Service on April 1, 2026. Posted in Public Companies.

CHICAGO and VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) — Green Thumb Industries Inc. (“Green Thumb” or the “Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced amendments to its brand licensing agreements with wholly-owned subsidiaries of RYTHM, Inc. (“RYTHM” or “RYM”) (Nasdaq: RYM). Effective April 1, 2026, GTI Core, LLC (“GTI Core”), an indirect wholly-owned subsidiary of the Company, has amended its existing Trademark and Recipe License Agreements with VCP IP Holdings, LLC and MC Brands LLC, both wholly-owned subsidiaries of RYTHM. Under the amended agreements, licensing fees transition from revenue-based fees to recurring fixed fees of $70 million cash per year collectively for the license rights to RYTHM...

RYTHM, Inc. Announces Amendments to License Agreements with Green Thumb Industries

Written by Customer Service on April 1, 2026. Posted in Public Companies.

ROLLING MEADOWS, Ill., April 01, 2026 (GLOBE NEWSWIRE) — RYTHM, Inc. (Nasdaq: RYM) (“RYTHM” or the “Company”), America’s THC Company, today announced amendments to its existing trademark and recipe license agreements with an indirect wholly-owned subsidiary of Green Thumb Industries Inc. (“Green Thumb”). RYTHM and Green Thumb have amended their existing trademark and recipe license agreements for the use of brand intellectual property which includes RYTHM, incredibles, Beboe, Dogwalkers, Doctor Solomon’s, &Shine, and Good Green. Effective April 1, 2026, Green Thumb will pay RYTHM an aggregate fixed annual cash fee of $70 million, subject to an annual increase equal to two times a Consumer Price Index-based escalator. “These amendments create a framework that strengthens our licensing arrangement with Green Thumb over the long...

Tilray Brands Delivers Record Q3 Fiscal 2026 Results; Net Revenue Increases to $207 Million with 11% Organic Growth and Gross Profit Expands to $55 Million, Increasing 6% Year-Over-Year

Written by Customer Service on April 1, 2026. Posted in Earnings Releases And Operating Results.

International Cannabis Accelerates with 73% Net Revenue Growth and 100% Increase in Cannabis Flower Sales Volume Year-Over-Year Canadian Adult-Use and Medical Cannabis Net Revenue Combined Increased 8% Year-Over-Year; Tilray Maintains #1 Cannabis Leadership Position in Canada by Revenue BrewDog Acquisition1 for ~£40 Million Cash Positions Tilray as a Global Craft Beverage Leader with Multi-Region Expansion Across Europe, Middle East, Australia, Asia-Pacific and the U.S. Strong Balance Sheet Supports Growth with $265 Million in Cash and Marketable Securities2 and ~$3.5 Million Net Cash NEW YORK and LONDON and LEAMINGTON, Ontario, April 01, 2026 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”, “our”, “we” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis,...

FitLife Brands Announces Fourth Quarter and Full-Year 2025 Results

Written by Customer Service on April 1, 2026. Posted in Earnings Releases And Operating Results.

OMAHA, NE, April 01, 2026 (GLOBE NEWSWIRE) — FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the fourth quarter and full year ended December 31, 2025. Highlights for the fourth quarter ended December 31, 2025 include:Total revenue was $25.9 million, an increase of 73% compared to the fourth quarter of 2024. Wholesale revenue was $15.5 million, or 60% of total revenue, an increase of 213% compared to the fourth quarter of 2024. Online revenue was $10.5 million, or 40% of total revenue, an increase of 4% compared to the fourth quarter of 2024. Excluding the amortization of the inventory step-up related to the Irwin acquisition, gross margin was 37.0% compared to 41.4% during the fourth...

NewcelX Announces Pricing of $1.35 Million Equity Financing at 30% Premium Pricing

Written by Customer Service on April 1, 2026. Posted in Public Companies.

Financing reflects strong investor confidence and supports advancement of lead Type 1 Diabetes program ZURICH, Switzerland, April 01, 2026 (GLOBE NEWSWIRE) — NewcelX Ltd. (Nasdaq: NCEL), a clinical-stage biopharmaceutical company developing stem cell-based therapies for Type 1 Diabetes, today announced that it has entered into securities purchase agreements for a private placement at a purchase price of $2.75 per share, representing a 30% premium to the last closing price of the Company’s common shares on March 31, 2026. Pursuant to the terms of the securities purchase agreements, the Company is selling an aggregate of 490,907 common shares (and common share equivalents) and one series of warrants to purchase an aggregate of 687,270 common shares at an exercise price of $3.025 per share. The offering includes participation from...

Year: 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals